Among these 15 TAAbs, the levels of nine TAAbs (RUNX1T1, RAD23A, CAST, PRKCZ, SF3B3, SARS, DUSP6, PAIP1, and CRLF3) exhibited significantly higher in the HCC patients than that in the NC. This evidence concerns the gene RAD23A and hepatocellular carcinoma.